TMCnet News
Ocugen Inc. Announces John Paul Gabriel as Senior Vice President, Manufacturing and Supply ChainMALVERN, Pa., April 14, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that John Paul (J.P.) Gabriel will be joining as Senior Vice President (SVP), Manufacturing and Supply Chain. John Paul (J.P.) Gabriel is a seasoned biopharmaceutical manufacturing professional with over 25 years of industry experience. Over the course of his career, Mr. Gabriel has held leadership positions with Sanofi Pasteur (formerly Connaught Laboratories), Pfizer Vaccines (formerly Wyeth), Genentech/Roche, and most recently with Ultragenyx Pharmaceutical, where he was Vice President of Biologics and mRNA Manufacturing. “We are pleased to welcome J.P. to the Ocugen team as we continue to plan for COVAXIN manufacturing in the US. As an established biopharma and vaccines operations leader, J.P. brings a wealth of manufacturing experience that will be instrumental in the technology transfer from Bharat Biotech for manufacturing in the U.S. market,” said Dr. Shankar Musunuri, Chairman of the Board, Chief Executive Officer, and Co-founder of Ocugen. “I’m thrilled to be part of the Ocugen team and share the team’s dedication to save lives from COVID-19. Bringing COVAXIN to the US market will be an important addition to our national arsenal of vaccines against COVID-19,” said J.P. Gabriel, SVP, Manufacturing and Supply Chain of Ocugen. In addition to his expertise in biomanufacturing, Mr. Gabriel led teams in quality and validation and has extensive experience interacting with various international health authorities. e has broad international business knowledge gained from work assignments in Canada, Switzerland, Japan, Mexico, and the United States. Mr. Gabriel earned an Honors Bachelor of Science in Biological Sciences with a Major in Microbiology and Minor in Biotechnology from the University of Guelph in Canada and an Advanced Certificate in Regulatory Affairs from the University of California San Diego. About Ocugen, Inc. Cautionary Note on Forward-Looking Statements Ocugen Contact:
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/c6048f2f-29a9-4b24-8526-07d6e5371303 |